Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets

• Cinzia Lanzi,
• Edwin Alexander Yates,
• Giuliana Cassinelli

Affiliations

Cinzia Lanzi

Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Edwin Alexander Yates

Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom

Giuliana Cassinelli

Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy